Amgen Inc
$336.03
USD
Last updated on --.
24h volume762.48K
24h highest342.19 USD
24h lowest335.65 USD
24h Price movement-0.96%
AMGN recent prices
24 Hours
-0.96%-$3.260
30 days
-0.27%-$0.91
60 days
-2.72%-$9.500
90 days
-11.72%-$45.06
Key data
Previous close339.30 USD
Market cap179.05B USD
Volume762.48K
P/E ratio22.950000
Dividend yield (TTM)0.03%
Dividend amount2.5200 USD
Next ex-dividend date15 May 2026
Next payment date5 Jun 2026
EPS diluted (TTM)14.4400 USD
Net income (FY)7.80B USD
Revenue (FY)37.22B USD
Last report date1 May 2026
About Amgen Inc
HeadquartersTHOUSAND OAKS
Employees (FY)31.50K
Revenue per employee (FY)1.18M USD
Net income per employee (FY)247.62K USD
Listed onNasdaq
AMGN conversion tables
 |  |
|---|---|
| 0.5 AMGN | 168.01 USD |
| 1 AMGN | 336.03 USD |
| 5 AMGN | 1,680.18 USD |
| 10 AMGN | 3,360.37 USD |
| |
|---|---|
| 0.5 USD | 0.0014879 AMGN |
| 1 USD | 0.0029759 AMGN |
| 5 USD | 0.014879 AMGN |
| 10 USD | 0.029759 AMGN |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
AMGN is trading at $336.03, -0.96% over the last 24 hours. Track live moves on the price chart at the top of this page.
The AMGN stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. AMGN is currently trading at $336.03, -0.96% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on AMGN price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. AMGN's P/E ratio is currently 22.950000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from AMGN; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against AMGN's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Amgen Inc's market cap is currently 179.05B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume762.48K
24h highest342.19 USD
24h lowest335.65 USD
24h Price movement-0.96%
Start trade with AMGN Perpetual
Sign up to trade